Journals / Annals of Medical Research / 2019 / Cilt: 26 - Sayı: 9

Poor myocardial blush grade accompanies to higher sudden death risk scores of hypertrophic cardiomyopathy

Pages
2032–2038
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The area under the curve (AUC)was 0.712 (p=0.016).Conclusions: Our study results demonstrated the increased risk of sudden cardiac death accompanies poor myocardial blush gradein patients with HCM.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Hypertrophic cardiomyopathy (HCM) is predominantly inherited as an autosomal dominant disease.
📊
Key Findings & Data:The aim of our study wasto evaluate angiographic microvascular flow and predictors of poor MBG in patients with HCM.Material and Methods: Patients with poor MBG (MBG 0/1, n=43), and patients with normal MBG (MBG 2/3, n=15) were includedretrospectively.Results: Family history and left ventricular end-diastolic diameter were significantly higher in the poor MBG group (p = 0.025,p=0.021).
💡
Conclusion & Impact:The area under the curve (AUC)was 0.712 (p=0.016).Conclusions: Our study results demonstrated the increased risk of sudden cardiac death accompanies poor myocardial blush gradein patients with HCM.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Hypertrophic cardiomyopathy (HCM) is predominantly inherited as an autosomal dominant disease. The aim of our study wasto evaluate angiographic microvascular flow and predictors of poor MBG in patients with HCM.Material and Methods: Patients with poor MBG (MBG 0/1, n=43), and patients with normal MBG (MBG 2/3, n=15) were includedretrospectively.Results: Family history and left ventricular end-diastolic diameter were significantly higher in the poor MBG group (p = 0.025,p=0.021). Left atrium diameter and moderate to severe mitral regurgitation (MR) were significantly higher in the normal MBG group(p=0.034, p=0.002). Percentage of SCD risk was significantly higher in patients with poor MBG (p=0.014). Moderate and severe mitralregurgitation (odds ratio =0.013, p=0.004) and HCM-SCD risk score (odds ratio = 0,398, p=0.009) were found to be independentparameters for predicting poor myocardial blush grade. The cut-off value of HCM-SCD risk score obtained by ROC curve analysiswas 3.10 for the prediction of poor myocardial blush grade (sensitivity: 76.2%, specificity: 76.7%). The area under the curve (AUC)was 0.712 (p=0.016).Conclusions: Our study results demonstrated the increased risk of sudden cardiac death accompanies poor myocardial blush gradein patients with HCM. If confirmed by further studies, poor MBG may convey SCD-HCM risk of higher rates.

🔖

Cite This Article

YALÇIN, F., DUMAN, F., KAPLAN, M., AKKUŞ, O. (2022). Poor myocardial blush grade accompanies to higher sudden death risk scores of hypertrophic cardiomyopathy. Annals of Medical Research, Cilt: 26 - Sayı: 9, 2032–2038. https://ajindex.com/articles/446953

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Elliott PM, Anastasakis A, Borger MA, et al. Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-79
  2. Sorajja P, Ommen SR, Nishimura RA, et al. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation 2003;108:2342–8
  3. Griffin BP. In: Manual of Cardiovascular Medicine. 4th edition. PA, USA, Williams & Wilkins 2013.p.160–75
  4. Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37:3232–45
  5. Harjai KJ, Cheirif J, Murgo JP. Ischemia and atherosclerotic coronary artery disease in patients with hypertrophic cardiomyopathy: a review of incidence, pathophysiological mechanisms, clinical implications and management strategies. Coron. Artery Dis 1996;7:183–7
  6. Hirasaki S, Nakamura T, Kuribayashi T, et al. Abnormal course, abnormal flow, and systolic compression of the septal perforator associated with impaired myocardial perfusion in hypertrophic cardiomyopathy. Am Heart J 1999;137:109-17
  7. Allen BD, Choudhury L, Barker AJ, et al. Three-dimensional haemodynamics in patients with obstructive and nonobstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging 2015;16:29-36
  8. Tsvetkov H, Mosseri M. Myocardial blush grade: an interventional method for assessing myocardial perfusion. Isr Med Assoc J 2008;10:465-7
  9. Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93
  10. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2011;57:2389–97
  11. Tarantini G, Ramondo A, Napodano M, et al. Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. Am J Cardiol 2004;93:1081-5
  12. Young L, Smedira NG, Tower-Rader A, et al. Hypertrophic cardiomyopathy: A complex disease. Cleve Clin J Med 2018;85:399-411
  13. Gębka A, Rajtar-Salwa R, Dziewierz A, et al. Painful and painless myocardial ischemia detected by e